Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy

SIMPLE SUMMARY: Concurrent platinum-based chemoradiotherapy (CRT) followed by maintenance treatment with the PD-L1 inhibitor durvalumab is the most effective therapy in unresectable stage III non-small-cell lung cancer (NSCLC). However, severe toxicity of this approach may lead to an unsatisfactory...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaborowska-Szmit, Magdalena, Szmit, Sebastian, Olszyna-Serementa, Marta, Badurak, Paweł, Zajda, Katarzyna, Janowicz-Żebrowska, Anna, Piórek, Aleksandra, Knetki-Wróblewska, Magdalena, Jaśkiewicz, Piotr, Płużański, Adam, Krzakowski, Maciej, Kowalski, Dariusz M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954027/
https://www.ncbi.nlm.nih.gov/pubmed/36831618
http://dx.doi.org/10.3390/cancers15041277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954027/
https://www.ncbi.nlm.nih.gov/pubmed/36831618
http://dx.doi.org/10.3390/cancers15041277

Ejemplares similares